Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 22;2(3):e000218.
doi: 10.1136/esmoopen-2017-000218. eCollection 2017.

Heterogeneity of colon cancer: from bench to bedside

Marco C Merlano  1 , Cristina Granetto  1 , Elena Fea  1 , Vincenzo Ricci  1 , Ornella Garrone  1
Affiliations
Review

Heterogeneity of colon cancer: from bench to bedside

Marco C Merlano et al. ESMO Open. .

Abstract

The large bowel shows biomolecular, anatomical and bacterial changes that proceed from the proximal to the distal tract. These changes account for the different behaviour of colon cancers arising from the diverse sides of the colon-rectum as well as for the sensitivity to the therapy, including immunotherapy. The gut microbiota plays an important role in the modulation of the immune response and differs between the right colon cancer and the left colorectal cancer. The qualitative and quantitative difference of the commensal bacteria between the right side and the left side induces epigenetic changes in the intestinal epithelial cells as well as in the resident immune population. The second player in the pathological homeostasis of colorectal cancer is the differences of the genetic features of cancer cells and the different effects that microsatellite instability, chromosomal instability and the CpG island methylator phenotype induce on the immunological organisation of the tumour microenvironment. The third player is the immunological composition of the tumour microenvironment, which changes under the influence of both genetic structures and gut microbiota. All these three players influence each other. This review describes these three aspects, highlights their interactions and discusses data from reported clinical trials.

Keywords: Colon cancer; treatment response; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kroemer G, Galluzzi L, Zitvogel L, et al. . Colorectal Cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology 2015;4:e1058597 10.1080/2162402X.2015.1058597 - DOI - PMC - PubMed
    1. Mantovani A, Allavena P, Sica A, et al. . Cancer-related inflammation. Nature 2008;454:436–44. 10.1038/nature07205 - DOI - PubMed
    1. Pradere JP, Dapito DH, Schwabe RF. The Yin and Yang of Toll-like receptors in Cancer. Oncogene 2014;33:3485–95. 10.1038/onc.2013.302 - DOI - PMC - PubMed
    1. Colotta F, Allavena P, Sica A, et al. . Cancer-related inflammation, the seventh hallmark of Cancer: links to genetic instability. Carcinogenesis 2009;30:1073–81. 10.1093/carcin/bgp127 - DOI - PubMed
    1. Nagasaki T, Hara M, Nakanishi H, et al. . Interleukin-6 released by Colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer 2014;110:469–78. 10.1038/bjc.2013.748 - DOI - PMC - PubMed

LinkOut - more resources